Sign up
or
Register for free
BioNation
RSS
Companies
Jobs
Drugs
News
Home
News Center
Directory
Articles
Recent
News Center
Companies
Drugs
Marketed Drugs
Investigational Drugs
Jobs
Pharma & Biotech
Chemistry
Medtech
Healthcare
Food & Beverage
Finance
Shop
Market Research
Corporate Solutions
BioFinancial News
Pipeline News
More news
BIOFINANCIAL
NEWS
Today
|
RSS
Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development
Apr 29 2013
Regado Biosciences Files for a $75 Million IPO
SCIODERM CLOSES $16 MILLION IN SERIES A FINANCING
Acumen Pharmaceuticals Inc. Announces First Closing of $20 Million Series A Financing
PIPELINE
NEWS
Today
|
RSS
Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
May 7 2013
ABGENIX INC
AMGEN INC
CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma
Emergent BioSolutions Presents Preclinical Efficacy Data on ES414 Its Lead ADAPTIR Bispecific Therapeutic for Prostate Cancer
AVEO and Astellas Report FDA Oncologic Drug Advisory Committee Votes Tivozanib Application Did Not Demonstrate Favorable Benefit-to-Risk Evaluation in Treatment of Advanced Renal Cell Carcinoma
BIONATION
LOGIN
Email
Password
I've forgotten my password!
Create an account here!
CURRENT
ISSUES
Blog
